Your browser doesn't support javascript.
loading
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial.
Israelsen, Mads; Madsen, Bjørn Stæhr; Torp, Nikolaj; Johansen, Stine; Hansen, Camilla Dalby; Detlefsen, Sönke; Andersen, Peter; Hansen, Johanne Kragh; Lindvig, Katrine Prier; Rasmussen, Ditlev Nytoft; Thorhauge, Katrine Holtz; Kjærgaard, Maria; Karsdal, Morten; Hansen, Torben; Arumugam, Manimozhiyan; Trebicka, Jonel; Thiele, Maja; Krag, Aleksander.
Afiliação
  • Israelsen M; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark. Electronic address: mads.israelsen@rsyd.dk.
  • Madsen BS; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
  • Torp N; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Johansen S; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Hansen CD; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Detlefsen S; Department of Pathology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Andersen P; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
  • Hansen JK; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Lindvig KP; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Rasmussen DN; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
  • Thorhauge KH; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Kjærgaard M; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Karsdal M; Department of Molecular Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; Nordic Bioscience Biomarkers and Research, Herlev, Denmark.
  • Hansen T; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
  • Arumugam M; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; Novo Nordisk Foundation Center for Basic Metabolic Research, Universi
  • Trebicka J; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; Department of Internal Medicine B, Münster University Hospital, WWU,
  • Thiele M; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Krag A; Odense Liver Research Center, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Lancet Gastroenterol Hepatol ; 8(6): 523-532, 2023 06.
Article em En | MEDLINE | ID: mdl-36893774
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cirrose Hepática Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cirrose Hepática Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2023 Tipo de documento: Article